Blood pressure drugs Benicar, Benicar HCT, Azor and Tribenzor have been linked to a gastrointestinal disorder known as sprue-like enteropathy. With thousands of personal injury and wrongful death lawsuits already filed, drug company Daiichi Sankyo has offered $300 million to settle pending and unfiled claims.
- The Benicar settlement fund is accepting new claims.
- Deadline: August 23, 2017, 11:59 pm E.T.
Our experienced attorneys can help. Start the legal process immediately. Contact us today for a free consultation.
The deadline to file a new Benicar claim is fast approaching. Make sure your family’s legal rights are protected.
Did you notice a TV commercial about the recent Benicar settlement?
What Benicar Settlement TV Ads Don’t Tell You
Many law firms have begun to run ads on local stations, notifying hypertension patients and families that Daiichi Sankyo, the Japanese pharmaceutical company behind Benicar, has settled nearly 2,300 personal injury lawsuits for $300 million. The settlement, announced on August 1, 2017, is broad and comprehensive. As written, the agreement offers financial compensation to patients who took Benicar, Benicar HCT, Azor and / or Tribenzor and developed a range of gastrointestinal side effects.
While the attorneys at The Product Lawyers don’t produce TV commercials, our lawyers have proven an invaluable resource to many patients and families looking for help in the wake of Benicar-linked injuries.
Our experienced product liability lawyers are now offering free consultations to all interested parties. Hundreds of injured patients may still be able to file claims against the Benicar settlement fund, but there is a strict time limit. The fund will close to new claimants on August 23, 2017 at 11:59 pm E.T. This deadline applies both to personal injury lawsuits, filed by living patients, and wrongful death lawsuits brought by families who lost loved ones to alleged Benicar side effects.
Our firm stopped accepting Benicar cases on 8/22/17